Mutual of America Capital Management LLC Sells 3,141 Shares of Aflac Incorporated (NYSE:AFL)

Mutual of America Capital Management LLC cut its stake in shares of Aflac Incorporated (NYSE:AFLFree Report) by 4.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 62,068 shares of the financial services provider’s stock after selling 3,141 shares during the period. Mutual of America Capital Management LLC’s holdings in Aflac were worth $6,939,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the stock. Spinnaker Trust lifted its position in shares of Aflac by 2.7% during the third quarter. Spinnaker Trust now owns 3,620 shares of the financial services provider’s stock valued at $405,000 after purchasing an additional 95 shares in the last quarter. Secure Asset Management LLC increased its position in shares of Aflac by 1.0% during the 3rd quarter. Secure Asset Management LLC now owns 9,783 shares of the financial services provider’s stock valued at $1,094,000 after purchasing an additional 96 shares during the last quarter. Ascent Group LLC boosted its holdings in shares of Aflac by 0.6% in the 2nd quarter. Ascent Group LLC now owns 17,231 shares of the financial services provider’s stock worth $1,539,000 after buying an additional 99 shares during the last quarter. Ieq Capital LLC grew its position in Aflac by 0.5% during the second quarter. Ieq Capital LLC now owns 21,775 shares of the financial services provider’s stock valued at $1,945,000 after buying an additional 101 shares during the period. Finally, New Century Financial Group LLC increased its holdings in Aflac by 2.5% during the third quarter. New Century Financial Group LLC now owns 4,198 shares of the financial services provider’s stock worth $469,000 after buying an additional 101 shares during the last quarter. 67.44% of the stock is currently owned by institutional investors.

Aflac Stock Performance

Aflac stock opened at $112.04 on Tuesday. The firm’s 50 day simple moving average is $110.46 and its 200 day simple moving average is $99.89. The company has a current ratio of 0.08, a quick ratio of 0.08 and a debt-to-equity ratio of 0.32. Aflac Incorporated has a 1-year low of $75.07 and a 1-year high of $115.50. The firm has a market capitalization of $62.24 billion, a PE ratio of 16.87, a price-to-earnings-growth ratio of 2.15 and a beta of 0.96.

Aflac (NYSE:AFLGet Free Report) last released its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share for the quarter, topping the consensus estimate of $1.69 by $0.47. The firm had revenue of $2.95 billion for the quarter, compared to analysts’ expectations of $4.30 billion. Aflac had a net margin of 22.02% and a return on equity of 16.34%. The business’s quarterly revenue was down 40.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.84 earnings per share. As a group, analysts expect that Aflac Incorporated will post 7.22 earnings per share for the current fiscal year.

Aflac Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 2nd. Stockholders of record on Wednesday, November 20th will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Wednesday, November 20th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.79%. Aflac’s dividend payout ratio (DPR) is presently 30.12%.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on AFL. Citigroup boosted their target price on shares of Aflac from $84.00 to $93.00 and gave the company a “neutral” rating in a research note on Tuesday, July 23rd. Piper Sandler increased their price objective on Aflac from $114.00 to $122.00 and gave the company an “overweight” rating in a report on Wednesday, October 2nd. Barclays began coverage on Aflac in a research note on Wednesday, September 4th. They issued an “underweight” rating and a $96.00 target price on the stock. JPMorgan Chase & Co. increased their price target on Aflac from $85.00 to $90.00 and gave the stock a “neutral” rating in a research note on Thursday, October 3rd. Finally, Bank of America upped their price objective on shares of Aflac from $115.00 to $124.00 and gave the company a “buy” rating in a report on Thursday, October 10th. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the company. According to MarketBeat.com, Aflac presently has an average rating of “Hold” and a consensus target price of $97.93.

Read Our Latest Research Report on Aflac

About Aflac

(Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Featured Articles

Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFLFree Report).

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.